12 Health Care Stocks Moving In Friday's Pre-Market Session

-38.30% Pre

0.00% Pre

+2.31% Pre

-1.26% Pre

Akari Therapeutics Plc Sponsored ADR

AKTX

0.25

0.26

-38.30%

+3.67% Pre

Bellerophon Therapeutics, Inc.

BLPH

0.00% Pre

Bio-Path Holdings, Inc.

BPTH

0.00% Pre

NUWELLIS INC

NUWE

2.21

+2.31%

0.00% Pre

Outset Medical

3.92

-1.26%

0.00% Pre

Gainers

Bio-Path Hldgs (NASDAQ:BPTH) stock rose 132.2% to $0.92 during Friday's pre-market session. The company's market cap stands at $10.4 million.
Redhill Biopharma (NASDAQ:RDHL) stock moved upwards by 34.4% to $0.5. The company's market cap stands at $2.9 million.
Akari Therapeutics (NASDAQ:AKTX) shares rose 14.52% to $4.02. The market value of their outstanding shares is at $20.3 million.
TRACON Pharma (NASDAQ:TCON) stock moved upwards by 14.42% to $0.22. The market value of their outstanding shares is at $6.7 million.
Petros Pharma (NASDAQ:PTPI) shares increased by 13.94% to $1.74. The company's market cap stands at $3.6 million.
Sera Prognostics (NASDAQ:SERA) shares increased by 12.76% to $2.12. The company's market cap stands at $66.3 million.

Losers

Outset Medical (NASDAQ:OM) shares declined by 39.3% to $4.11 during Friday's pre-market session. The market value of their outstanding shares is at $204.6 million.
Nuwellis (NASDAQ:NUWE) shares decreased by 35.15% to $0.66. The market value of their outstanding shares is at $1.2 million.
Bellerophon Therapeutics (NASDAQ:BLPH) shares decreased by 31.86% to $0.26. The company's market cap stands at $3.2 million.
Cassava Sciences (NASDAQ:SAVA) shares decreased by 29.88% to $12.3. The market value of their outstanding shares is at $516.2 million.
OpGen (NASDAQ:OPGN) shares fell 25.1% to $0.69. The market value of their outstanding shares is at $6.1 million.
Reshape Lifesciences (NASDAQ:RSLS) shares decreased by 16.18% to $0.28. The market value of their outstanding shares is at $1.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.